Telglenz-CH 40/12.5 Tablet
Marketer
Cardio Renal Metabolic Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Chlorthalidone (12.5mg)
Overview Telglenz-CH 40/12.5 Tablet
Combivent-CH 40/12.5mg tablets combine two medications to effectively manage hypertension. This dual action reduces the long-term risk of stroke and heart attack. Combivent-CH 40/12.5mg can be taken with or without food; dosage is tailored to individual response and health status. Consistent daily timing is recommended. Continue taking this medication as prescribed by your physician. The formulation includes a diuretic, increasing urine production; therefore, avoid taking it within four hours of bedtime. Regular use is crucial for optimal benefit, even during periods of well-being. Hypertension is often asymptomatic; discontinuing treatment increases cardiovascular risks. Dizziness is a common side effect, while others include nausea, diarrhea, headache, and altered lipid profiles. Increased urination is an expected diuretic effect, integral to blood pressure control. Less frequent side effects are also possible. Always review the accompanying patient information leaflet and report any persistent or bothersome side effects to your doctor; dosage adjustment or alternative therapies may be considered. This medication is not advised during pregnancy and requires consultation with your doctor if you have pre-existing kidney, liver, heart, or diabetic conditions. Alcohol consumption may intensify blood pressure reduction and potentially exacerbate side effects.
Primary Ingredients of Telglenz-CH 40/12.5 Tablet
No information provided. Therefore, no rephrased text can be given.
Uses of Telglenz-CH 40/12.5 Tablet
Elevated blood pressure
Major Benefits of Telglenz-CH 40/12.5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Telglenz-CH 40/12.5 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Telglenz-CH 40/12.5 Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Telglenz-CH 40/12.5 Tablet:
Administer Telglenz-CH 40/12.5 tablets precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Telglenz-CH 40/12.5 Tablet works:
Each Telglenz-CH 40/12.5 tablet contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Telglenz-CH 40/12.5 Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Telglenz-CH 40/12.5 Tablet is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
The medication Telglenz-CH 40/12.5 Tablet is contraindicated during lactation. Evidence indicates potential infant toxicity.
DrivingUNSAFE
Taking Telglenz-CH 40/12.5 Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Caution is advised when prescribing Telglenz-CH 40/12.5 Tablets to individuals with severely impaired kidney function. Dosage modification may be necessary; physician consultation is recommended. This medication is contraindicated for patients with such conditions.
LiverCAUTION
Patients with liver impairment should exercise caution when using Telglenz-CH 40/12.5 Tablets, as dosage modification may be necessary. Consult your physician for guidance. Telglenz-CH 40/12.5 Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Telglenz-CH 40/12.5 Tablet :
Should you forget a Telglenz-CH 40/12.5 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telglenz-CH 40/12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |



